EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) stock enjoyed a major increase of 27.6% on 10/28/24. The shares closed at $12.12. Moreover, this advance was accompanied by exceptionally high trading volume at 723% of normal. Relative to the market the stock has been extremely weak over the last nine months but has risen 9.7% during the last week.
Current PriceTarget Research Rating
EYPT is expected to continue to be a modest Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
EyePoint Pharmaceuticals has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. EyePoint Pharmaceuticals has a neutral Appreciation Score of 45 but a very low Power Rating of 0, resulting in the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment